REITER 	REITER 	 NNP	B-NP
'S  	'S  	 POS	O
SYNDROME  	SYNDROME  	 NNP	O
FOLLOWING  	FOLLOWING  	 NNP	O
INTRAVASICAL  	INTRAVASICAL  	 NNP	B-NP
BCG  	BCG  	 NNP	I-NP
THERAPY  	THERAPY  	 NNP	I-NP
FOR  	FOR  	 IN	I-NP
UROTHELIAL  	UROTHELIAL  	 NNP	I-NP
CARCINOMA 	CARCINOMA 	 NNP	I-NP
.  	.  	 .	O
SUMMARY  	SUMMARY  	 NN	O
OF  	OF  	 IN	O
CASE  	CASE  	 NN	B-NP
REPORTS  	REPORTS  	 NNS	I-NP
OVER  	OVER  	 IN	O
THE  	THE  	 DT	O
PAST  	PAST  	 NNP	O
13  	13  	 CD	O
YEARS  	YEARS  	 NNS	O
IN  	IN  	 IN	O
JAPAN 	JAPAN 	 NNP	O
,  	,  	 ,	O
INCLUDING  	INCLUDING  	 NNP	O
OUR  	OUR  	 NNP	O
CURRENT  	CURRENT  	 NNP	O
6  	6  	 CD	O
CASES  	CASES  	 NNP	O
Reiter 	Reiter 	 NNP	O
's  	's  	 POS	O
syndrome  	syndrome  	 NN	O
is  	is  	 VBZ	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
rare  	rare  	 JJ	O
complications  	complications  	 NNS	B-NP
following  	following  	 VBG	O
intravesical  	intravesical  	 JJ	B-NP
bovis  	bovis  	 JJ	I-NP
Bacillus  	Bacillus  	 NN	I-NP
Calmette-Guerin  	Calmette-Guerin  	 NNS	I-NP
( 	( 	 -LRB-	O
BCG 	BCG 	 NNP	B-NP
)  	)  	 -RRB-	O
treatment 	treatment 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study  	study  	 NN	O
we  	we  	 PRP	O
have  	have  	 VBP	O
reviewed  	reviewed  	 VBN	O
and  	and  	 CC	O
discussed  	discussed  	 VBD	O
101  	101  	 CD	O
cases  	cases  	 NNS	O
including  	including  	 VBG	O
our  	our  	 PRP$	O
own  	own  	 JJ	O
6  	6  	 CD	O
cases  	cases  	 NNS	O
over  	over  	 IN	O
the  	the  	 DT	O
past  	past  	 JJ	O
13  	13  	 CD	O
years  	years  	 NNS	O
in  	in  	 IN	O
Japan  	Japan  	 NNP	O
( 	( 	 -LRB-	O
2000-2013 	2000-2013 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
patients  	patients  	 NNS	O
comprised  	comprised  	 VBD	O
70  	70  	 CD	O
males  	males  	 NNS	O
and  	and  	 CC	O
25  	25  	 CD	O
females  	females  	 NNS	O
( 	( 	 -LRB-	O
6  	6  	 CD	O
cases  	cases  	 NNS	O
were  	were  	 VBD	O
unknown 	unknown 	 JJ	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
mean  	mean  	 JJ	O
age  	age  	 NN	O
of  	of  	 IN	O
63.1  	63.1  	 CD	O
( 	( 	 -LRB-	O
range  	range  	 NN	O
42  	42  	 CD	O
-  	-  	 :	O
91 	91 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Arthritis  	Arthritis  	 NNP	O
occured  	occured  	 VBD	O
4-5  	4-5  	 CD	O
days  	days  	 NNS	O
after  	after  	 IN	O
conjunctivitis 	conjunctivitis 	 NN	B-NP
.  	.  	 .	O
Thirty  	Thirty  	 CD	O
five  	five  	 CD	O
( 	( 	 -LRB-	O
55 	55 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
of  	of  	 IN	O
68  	68  	 CD	O
patients  	patients  	 NNS	O
needed  	needed  	 VBD	O
corticosteroid  	corticosteroid  	 JJ	B-NP
treatment  	treatment  	 NN	I-NP
to  	to  	 TO	O
control  	control  	 VB	O
their  	their  	 PRP$	O
arthritis 	arthritis 	 NN	O
.  	.  	 .	O
HLA-B27  	HLA-B27  	 NNP	B-NP
is  	is  	 VBZ	O
known  	known  	 VBN	O
as  	as  	 IN	O
a  	a  	 DT	O
risk  	risk  	 NN	B-NP
factor  	factor  	 NN	I-NP
of  	of  	 IN	O
Reiter 	Reiter 	 NNP	O
's  	's  	 POS	O
syndrome 	syndrome 	 NN	O
,  	,  	 ,	O
however 	however 	 RB	O
,  	,  	 ,	O
positive  	positive  	 JJ	B-NP
rate  	rate  	 NN	I-NP
was  	was  	 VBD	O
only  	only  	 RB	O
2.4 	2.4 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
41 	41 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
